DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Food and Drug Administration.
FDA approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients.
2017–06–23. Available at:
https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564422.htm . Accessed July 3, 2017
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.